Characteristics | n (%) |
---|---|
Number of patients | 683 |
Age, years, median (range) | 66 (29–90) |
Gender | |
Male | 409 (59.9%) |
Female | 174 (40.1%) |
Tumor diameter (cm), median (range) | 3.6 (0.6–9.0) |
TNM stage, seventh edition | |
IA | 10 (1.5%) |
IB | 97 (14.2%) |
IIA | 141 (20.6%) |
IIB | 266 (38.9%) |
III | 169 (24.7%) |
TNM stage, eighth edition | |
IA | 10 (1.5%) |
IB | 101 (14.8%) |
IIA | 137 (20.1%) |
IIB | 154 (22.5%) |
III | 281 (41.1%) |
Prescription dose (Gy), median (range) | 37 (32.5–49.6)/5-8f |
BED10 (Gy), median (range) | 61.92 (53.625–88.32)/5-8f |